Glaxo Wellcome Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 1

Glaxo Wellcome General Information

Description

Operator of a pharmaceutical firm serving the healthcare industry. The company specializes in functional-genomics programs and invests heavily in pharmacogenetics, a genomics-based activity allowing patients likely to benefit from a drug, or to suffer adverse side effects, to be identified before therapy is selected.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • P.O. Box 13398
  • Research Triangle Park, NC 27709
  • United States
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • P.O. Box 13398
  • Research Triangle Park, NC 27709
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glaxo Wellcome Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Glaxo Wellcome‘s full profile, request access.

Request a free trial

Glaxo Wellcome Patents

Glaxo Wellcome Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2763507-B1 Inhaler Inactive 23-May-1997
FR-2763507-A1 Inhaler with sound unit Active 23-May-1997
GB-9609820-D0 Chemical compounds Pending 10-May-1996
GB-9609777-D0 Chemical compounds Pending 10-May-1996
GB-9525240-D0 Ranitidine compositions Pending 09-Dec-1995
To view Glaxo Wellcome’s complete patent history, request access »

Glaxo Wellcome Acquisitions (1)

Glaxo Wellcome’s most recent deal was a Merger/Acquisition with MediKredit Integrated Healthcare Solutions. The deal was made on 09-May-1995.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
MediKredit Integrated Healthcare Solutions 09-May-1995 Merger/Acquisition Other Healthcare Technology Systems
To view Glaxo Wellcome’s complete acquisitions history, request access »

Glaxo Wellcome Exits (1)

Glaxo Wellcome’s most recent exit was on 09-May-1995 from MediKredit Integrated Healthcare Solutions. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
MediKredit Integrated Healthcare Solutions 09-May-1995 Completed
  • 2 buyers
To view Glaxo Wellcome’s complete exits history, request access »

Glaxo Wellcome FAQs

  • When was Glaxo Wellcome founded?

    Glaxo Wellcome was founded in 1995.

  • Where is Glaxo Wellcome headquartered?

    Glaxo Wellcome is headquartered in Research Triangle Park, NC.

  • What industry is Glaxo Wellcome in?

    Glaxo Wellcome’s primary industry is Pharmaceuticals.

  • Is Glaxo Wellcome a private or public company?

    Glaxo Wellcome is a Private company.

  • What is Glaxo Wellcome’s current revenue?

    The current revenue for Glaxo Wellcome is .

  • When was Glaxo Wellcome acquired?

    Glaxo Wellcome was acquired on 08-May-2000.

  • Who acquired Glaxo Wellcome?

    Glaxo Wellcome was acquired by GSK.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »